(Q45212721)

10 December 2017

Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome (English)

1 reference

10 December 2017

0 references

1 reference

chronic schizophrenia

1 reference

1 reference

coronary artery disease

1 reference

3

1 reference

10 December 2017

5

Gary Remington

1 reference

10 December 2017

Tony Cohn

1

1 reference

10 December 2017

Denis Prud'homme

series ordinal

2

1 reference

10 December 2017

Homa Kameh

series ordinal

4

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

Canadian Journal of Psychiatry

10 December 2017

1 reference

10 December 2017

49

1 reference

10 December 2017

11

1 reference

10 December 2017

753-760

1 reference

Schizophrenia: a life-shortening disease.

10 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Mortality in a cohort of patients with schizophrenia: a record linkage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Excess mortality of schizophrenia. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Excess mortality among psychiatric patients. The Iowa Record-Linkage Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Mortality and causes of death in first admitted schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Causes of the excess mortality of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Mortality and causes of death in schizophrenia in Stockholm county, Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Diabetes mellitus in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Prevalence and correlates of diabetes in national schizophrenia samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Atypical antipsychotics and weight gain--a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Weight gain from novel antipsychotic drugs: need for action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Atypical antipsychotics and hyperglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Novel antipsychotics and severe hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Role of insulin resistance in human disease (syndrome X): an expanded definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Medical comorbidity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

The association of medical comorbidity in schizophrenia with poor physical and mental health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Prevention of coronary heart disease by diet and lifestyle: evidence from prospective cross-cultural, cohort, and intervention studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Physical Activity in the Prevention of Atherosclerotic Coronary Heart Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Smoking cessation for the secondary prevention of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370404901106

Smoking cessation for the secondary prevention of coronary heart disease.

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD003041

10.1177/070674370404901106

30 December 2023

Identifiers

DOI

0 references

1 reference